Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nexalin Technology Granted U.S. Patent #11944806: Transcranial alternating current dynamic frequency stimulation method for anxiety, depression, and insomnia

Author: Charles Gross | April 02, 2024 12:01pm

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11944806

Posted In: NXL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist